Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
United States Department of Defense | United States Navy | Office of Naval Research (N00014-21-1-2195)
MIT Research Support Committee
Machine Learning for Pharmaceutical Discovery and Synthesis consortium
- License Information
-
More Information
Article History
Received: 14 December 2021
Accepted: 8 February 2022
First Online: 28 February 2022
Competing interests
: C.W.C. is a scientific advisor to and shareholder of companies including Entos, Inc. and Kebotix. W.G. and P.R. declare no competing interests.
